{"organizations": [], "uuid": "a04cd990d831cf47cc656ef2e80e46f23ca77384", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-invivo-therapeutics-says-there-is/brief-invivo-therapeutics-says-there-is-substantial-doubt-about-ability-to-continue-as-a-going-concern-idUSFWN1PO0KR", "country": "US", "domain_rank": 408, "title": "BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-29T13:22:00.000+02:00", "replies_count": 0, "uuid": "a04cd990d831cf47cc656ef2e80e46f23ca77384"}, "author": "", "url": "https://www.reuters.com/article/brief-invivo-therapeutics-says-there-is/brief-invivo-therapeutics-says-there-is-substantial-doubt-about-ability-to-continue-as-a-going-concern-idUSFWN1PO0KR", "ord_in_thread": 0, "title": "BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "going concern reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "invivo therapeutics", "sentiment": "none"}, {"name": "invivo therapeutics holdings corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 29, 2018 / 11:23 AM / in 9 minutes BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern Reuters Staff 1 Min Read \nJan 29 (Reuters) - Invivo Therapeutics Holdings Corp : \n* INVIVO THERAPEUTICS SAYS “THERE IS SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN” - SEC FILING \n* INVIVO THERAPEUTICS - CURRENT CASH RESOURCES WILL NOT BE SUFFICIENT TO COMPLETE CLINICAL DEVELOPMENT OF NEURO-SPINAL SCAFFOLD IMPLANT Source text: ( bit.ly/2rOeCK6 ) Further company coverage:", "external_links": [], "published": "2018-01-29T13:22:00.000+02:00", "crawled": "2018-01-29T13:47:04.027+02:00", "highlightTitle": ""}